norethindrone has been researched along with Insulin Resistance in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cagnacci, A; D'Alterio, MN; Di Carlo, C; Melis, GB; Neri, M; Orrù, MM; Paoletti, AM | 1 |
| Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A | 1 |
| Godsland, IF; Manassiev, N; Proudler, AJ; Stevenson, JC; Whitehead, MI | 1 |
| Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V | 1 |
| Fernandes, CE; Ferreira, JA; Machado, RB; Melo, NR; Peixoto, S; Pompei, LM | 1 |
| Gossain, VV; Michelakis, AM; Rovner, DR; Sherma, NK | 1 |
| Bender, R; Berger, M; Heinemann, L; Heise, T; Hirschberger, S; Kimmerle, R; Weyer, C | 1 |
| Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V | 1 |
| Hager, SR; Kalkhoff, RK | 1 |
| Givens, JR; Goodman, RC | 1 |
| Godsland, I; Wynn, V | 1 |
| Moore, DC | 1 |
5 trial(s) available for norethindrone and Insulin Resistance
| Article | Year |
|---|---|
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
Topics: Adipose Tissue; Androstenes; Body Composition; Body Water; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Insulin Resistance; Middle Aged; Mineralocorticoid Receptor Antagonists; Norethindrone; Postmenopause; Progesterone Congeners; Quality of Life; Treatment Outcome | 2015 |
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies | 2008 |
Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism.
Topics: Aged; Blood Glucose; C-Peptide; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Glucose; Humans; Insulin; Insulin Resistance; Middle Aged; Norethindrone; Norpregnenes | 2013 |
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow.
Topics: Carotid Arteries; Coronary Artery Disease; Double-Blind Method; Drug Interactions; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipids; Middle Aged; Norethindrone; Pulsatile Flow | 2008 |
Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Topics: Aged; Analysis of Variance; Blood Glucose; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin; Insulin Resistance; Insulin Secretion; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Treatment Outcome | 1999 |
7 other study(ies) available for norethindrone and Insulin Resistance
| Article | Year |
|---|---|
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone | 2005 |
Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
Topics: Administration, Oral; Adolescent; Adult; Arginine; Blood Glucose; Contraceptives, Oral, Combined; Drug Combinations; Female; Glucagon; Glucose Tolerance Test; Humans; Infusions, Parenteral; Insulin; Insulin Resistance; Mestranol; Norethindrone | 1983 |
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes | 1992 |
Levonorgestrel and norethindrone alter insulin action on skeletal muscle of the female rat.
Topics: Animals; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Glucose; Hindlimb; Insulin; Insulin Antagonists; Insulin Resistance; Levonorgestrel; Muscles; Norethindrone; Norgestrel; Phenylalanine; Progesterone Congeners; Rats; Rats, Inbred Strains | 1990 |
Hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Insulin Resistance; Luteinizing Hormone; Mestranol; Norethindrone; Polycystic Ovary Syndrome | 1986 |
Effects of oral contraceptives on carbohydrate metabolism.
Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norethindrone; Norgestrel | 1986 |
Prolonged suppression of hirsutism with combination therapy in an adolescent with insulin resistance and acanthosis nigricans.
Topics: Acanthosis Nigricans; Adolescent; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin Resistance; Norethindrone; Spironolactone; Syndrome | 1987 |